ABCELLERA BIOLOGICS INC
ABCLNASDAQ🏆 #1591 by market capEarnings Nov 5US Equity
$10.02▲ $0.27 (+2.66%)
Live1h▲ 0.7%
24h▲ 2.7%
7d▲ 68.8%
14d▲ 85.6%
30d▲ 53.9%
1y▲ 135.2%
🏦Market Cap
$3.06B
Small Cap
📈Revenue Growth (YoY)
+160.6%
High Growth
📊Gross Margin
75.0%
High
💵FCF Margin
-271.2%
Thin
⚖️P/S Ratio
45.0x
Expensive
Otter Score
54
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-0.18
Expected
-0.16
miss
−9.80%
YoY −50.00%
Revenue
Actual
$4.05M
Expected
$7.85M
miss
−48.40%
YoY −76.30%
Consensus estimates
Recent quarters
Q3 2026
-0.18
miss
Q2 2026
-0.14
beat
Q1 2026
-0.03
beat
Q4 2025
-0.19
miss